Phase 1 Study to Evaluate the Safety and Tolerability of VK2735
Clinical trial NCT05203237 · COMPLETED
Trial details
- NCT number
- NCT05203237
- Sponsor
- Viking Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-11-04
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.